Compare · EW vs SERV
EW vs SERV
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Serve Robotics Inc. (SERV): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while SERV operates in Consumer Discretionary - the two are in different parts of the market.
- EW carries a market cap of $50.78B.
- Over the past year, EW is up 16.0% and SERV is down 77.5% - EW leads by 93.5 points.
- SERV has been more active in the news (6 items in the past 4 weeks vs 5 for EW).
- EW has more recent analyst coverage (25 ratings vs 9 for SERV).
- Company
- Edwards Lifesciences Corporation
- Serve Robotics Inc.
- Price
- -
- -
- Market cap
- $50.78B
- -
- 1M return
- -1.84%
- -24.80%
- 1Y return
- +16.04%
- -77.45%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 5
- 6
- Recent ratings
- 25
- 9
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest SERV
- SEC Form 4 filed by Serve Robotics Inc.
- SEC Form 4 filed by Serve Robotics Inc.
- SEC Form 4 filed by Serve Robotics Inc.
- SEC Form 8-K filed by Serve Robotics Inc.
- Serve Robotics to Present at Evercore ISI's 5th Annual Automation Tech & Physical AI Conference
- SEC Form S-8 filed by Serve Robotics Inc.
- China's Robot Boom Is Raising Security Fears as the US Robotics Race Accelerates
- Chief Financial Officer Read Brian sold $206,766 worth of shares (41,069 units at $5.03), decreasing direct ownership by 13% to 276,002 units (SEC Form 4) to cover taxes
- President & COO Parang Touraj sold $172,703 worth of shares (37,993 units at $4.55), decreasing direct ownership by 3% to 1,260,251 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Kashani Ali sold $205,920 worth of shares (45,158 units at $4.56), decreasing direct ownership by 1% to 3,232,933 units (SEC Form 4) to cover withholding tax